Is AMH a promising predictive biomarker for mTESE success in iNOA patients?

Julia Uraji; Juan J Fraire-Zamora; Claudia Massarotti; Sofia Makieva; George Liperis; Kashish Sharma; Sarah Martins Da Silva; Raevti Bole; Jackson C. Kirkman-Brown; Omar Farhan Ammar

doi:10.1093/humrep/deae179

Is AMH a promising predictive biomarker for mTESE success in iNOA patients?

Julia Uraji, Juan J Fraire-Zamora, Claudia Massarotti, Sofia Makieva, George Liperis, Kashish Sharma, Sarah Martins Da Silva, Raevti Bole, Jackson C. Kirkman-Brown, Omar Farhan Ammar (Lead / Corresponding author)

Diabetes Endocrinology and Reproductive Biology

Research output: Contribution to journal › Article › peer-review

Abstract

The September ESHRE Journal Club discussion focused on a study by Pozzi et al. that addressed the current standards in diagnostic male reproductive health, and whether or not AMH testing should be included in the future; what the possible mechanisms behind the link of AMH and sperm retrieval may be; how DCA can help us to understand prediction tools and models in clinical practice; and to what extent a high AMH level should alter the course of treatment in iNOA patients. AMH, anti-M€ ullerian hormone; iNOA, idiopathic non-obstructive azoospermia; DCA, decision curve analysis; mTESE, micro-dissection testicular sperm extraction.

Original language	English
Article number	deae179
Number of pages	7
Journal	Human Reproduction
DOIs	https://doi.org/10.1093/humrep/deae179
Publication status	Published - 7 Aug 2024

Keywords

ESHREjc
Journal Club
mTESE
iNOA
biomarkers

Access to Document

10.1093/humrep/deae179

Embargoed Document

Author Accepted Manuscript
Accepted author manuscript, 205 KB
Embargo ends: 7/08/25

Cite this

@article{e17eec3776764606bb4863df7ef515fc,

title = "Is AMH a promising predictive biomarker for mTESE success in iNOA patients?",

abstract = "The September ESHRE Journal Club discussion focused on a study by Pozzi et al. that addressed the current standards in diagnostic male reproductive health, and whether or not AMH testing should be included in the future; what the possible mechanisms behind the link of AMH and sperm retrieval may be; how DCA can help us to understand prediction tools and models in clinical practice; and to what extent a high AMH level should alter the course of treatment in iNOA patients. AMH, anti-M€ ullerian hormone; iNOA, idiopathic non-obstructive azoospermia; DCA, decision curve analysis; mTESE, micro-dissection testicular sperm extraction.",

keywords = "ESHREjc, Journal Club, mTESE, iNOA, biomarkers",

author = "Julia Uraji and Fraire-Zamora, {Juan J} and Claudia Massarotti and Sofia Makieva and George Liperis and Kashish Sharma and {Martins Da Silva}, Sarah and Raevti Bole and Kirkman-Brown, {Jackson C.} and Ammar, {Omar Farhan}",

year = "2024",

month = aug,

day = "7",

doi = "10.1093/humrep/deae179",

language = "English",

journal = "Human Reproduction",